Posted by Michael Wonder on 15 Sep 2022
Mallinckrodt receives US FDA approval for Terlivaz (terlipressin) for injection for the treatment of hepatorenal syndrome
14 September 2022 - Terlivaz is the first and only FDA approved treatment for adults with hepatorenal syndrome involving rapid reduction in kidney function.
Mallinckrodt today announced that the U.S. FDA approved Terlivaz (terlipressin) for injection.
